Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
07/17/2007 | US7244818 Interferon alpha responsive protein |
07/17/2007 | US7244814 Variant Tat proteins and methods for use thereof |
07/17/2007 | US7244768 Side effect reduction |
07/17/2007 | US7244743 Non-peptidic BRS-3 agonists |
07/17/2007 | US7244721 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
07/17/2007 | US7244718 Derivatives of water insoluble drugs which exhibit good activity and water solubility; producing an anesthetic effect in a dog |
07/17/2007 | US7244715 Vaccines containing ribavirin and methods of use thereof |
07/17/2007 | US7244711 Mixtures of enzyme inhibitors and free radical scavengers selected from phenolic compounds, phenothiazines and diphenylamines, used for prophylaxis of rheumatic diseases, pancreatitis, multiple sclerosis or gastrointestinal disorders |
07/17/2007 | US7244710 Treatment of ophthalmic infections using antimicrobial peptides |
07/17/2007 | US7244709 comprising an aqueous mixture of parathyroid hormone, a cyclodextran and didecanoylphosphatidylcholine at concentrations sufficient to enhance permeation across the cellular layer, wherein the formulation consists of droplets, of which less than 10% are less than 10 microns in diameter |
07/17/2007 | US7244708 Inhibitors of memapsin 2 and use thereof |
07/17/2007 | US7244707 method to adjust the behaviour of cytotrophoblast cells of the placenta and that of stem cells by administering an effective amount of insulin-like growth factor II; treatment of pregnant women or their embryos can be used to prevent recurrent spontaneous miscarriage and pre-eclampsia |
07/17/2007 | US7244706 For therapy of bacterial infections |
07/17/2007 | US7244705 Polyacid glycopeptide derivatives |
07/17/2007 | US7244704 Exploiting endogenous import and export mechanisms of ribonucleic acid trafficking which utilize nuclear targeting peptides containing nonclassical nuclear localization signals |
07/17/2007 | US7244703 Pharmaceutical compositions and methods for peptide treatment |
07/17/2007 | US7244702 siderophores; batch affinity chromatography; for detecting antibiotic resistance |
07/17/2007 | US7244701 For use in therapy and prophylaxis of hyponatremia, congestive heart failure, liver cirrhosis, nephrotic syndrome and hypertension |
07/17/2007 | US7244617 Generating transgenic cell comprising expression vector coding apotosis inducing factor for use in treatment of cell proliferative and viral disorders |
07/17/2007 | US7244615 Producing an antibody comprising complementarity determining regions, heavy and light chains, and non-human donor residues, a variable domain; used for in vivo therapy and diagnosis |
07/17/2007 | US7244604 HDAC9 polypeptides and polynucleotides and uses thereof |
07/17/2007 | US7244590 Regulatory protein for Nox enzymes |
07/17/2007 | US7244577 Method of screening for modulator of LRP5 activity |
07/17/2007 | US7244576 Modulators of angiogenesis |
07/17/2007 | US7244565 Gene shinc-3 and diagnostic and therapeutic uses thereof |
07/17/2007 | US7244557 Method of screening modulators of Nod1 signaling |
07/17/2007 | US7244437 Clostridial toxin derivatives and methods for treating pain |
07/17/2007 | US7244436 Clostridial toxin derivatives and methods for treating pain |
07/17/2007 | US7244428 PRO1357 antibodies |
07/17/2007 | US7244427 Isolated bovine IgG heavy chain protein and its use as an antimicrobial |
07/17/2007 | US7244426 Pharmaceutical compositions of fibrinolytic agent |
07/17/2007 | US7244425 Acid- and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol |
07/17/2007 | US7244423 delivery of a neurotrophin to targeted defective, diseased or damaged cholinergic neurons |
07/17/2007 | US7244422 Enhancing the effect of hepatitis vaccines, particularly hepatitus B vaccines, by the use of ribavirin as an adjuvant; single administration |
07/17/2007 | US7244412 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
07/17/2007 | US7244410 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
07/17/2007 | CA2494338C Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
07/17/2007 | CA2305655C Self-deleting vectors for cancer therapy |
07/17/2007 | CA2216167C Glycopeptide antibiotic derivatives |
07/17/2007 | CA2182013C Humanized antibodies against leukocyte adhesion molecule vla-4 |
07/17/2007 | CA2145535C Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
07/17/2007 | CA2115348C Process for the production of pharmaceutical preparations containing human protein for infusion or injection purposes |
07/17/2007 | CA2102594C Gene manipulation and expression using genomic elements |
07/12/2007 | WO2007079460A2 Design of cxc chemokine analogs for the treatment of human diseases |
07/12/2007 | WO2007079293A2 Cancer stem cells and uses thereof |
07/12/2007 | WO2007079130A2 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
07/12/2007 | WO2007078820A2 Methylmaleimidyl polymer derivatives |
07/12/2007 | WO2007078761A2 Method for prolonging activity of autodegradable enzymes and compositions thereof |
07/12/2007 | WO2007078726A2 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
07/12/2007 | WO2007078633A2 Bacteriocin inducer peptides |
07/12/2007 | WO2007078615A2 Methods and compositions for treatment of cancer |
07/12/2007 | WO2007077861A1 NF-κB INHIBITOR |
07/12/2007 | WO2007077465A2 Treatment of hiv |
07/12/2007 | WO2007077316A1 Method for preventing and/or treating articles or media contaminated with bacteria of the legionella genus |
07/12/2007 | WO2007077278A1 Non-proteolysable oligopeptides that inhibit glycoprotein gp41 of the aids virus |
07/12/2007 | WO2007077008A1 Chimaeric fusion protein with superior chaperone and folding activities |
07/12/2007 | WO2007076933A1 Interleukin-12p40 variants with improved stability |
07/12/2007 | WO2007076776A1 Method and device for vacuum drying papaya latex |
07/12/2007 | WO2007076701A1 Extended release of neuregulin for improved cardiac function |
07/12/2007 | WO2007076572A1 A method of treatment |
07/12/2007 | WO2007047577A3 Use of calcitonin-related peptide (cgrp) antagonists or release inhibitors for the treatment of sleep-related breathing disorders |
07/12/2007 | WO2007031329A3 Use of a collagen of xenogeneic origin |
07/12/2007 | WO2007028025A3 Methods and compositions for the treatment and prevention of cholera |
07/12/2007 | WO2007022518A3 New uses of glucoregulatory proteins |
07/12/2007 | WO2007014254A3 Method of treating or preventing tissue deterioration, injury or damage due to hypertrophic muscle disease |
07/12/2007 | WO2007014033A3 Inhibition of extracellular signal-regulated kinase 1/2 as a treatment for cardiac hypertrophy and heart failure |
07/12/2007 | WO2007012976A3 Airway administration of activated protein c in inflammatory conditions affecting the respiratory tract |
07/12/2007 | WO2007006041A8 Imaging and therapeutic method using monocytes |
07/12/2007 | WO2007005948A3 Methods and compositions for diagnosis and treatment of viral and bacterial infections |
07/12/2007 | WO2007001183A3 Hecgf-1 related polymorphisms and applications thereof |
07/12/2007 | WO2006138468A3 Use of vegf for wound healing |
07/12/2007 | WO2006136963A3 Airway administration of site-inactivated fviia in inflammatory conditions affecting the respiratory tract |
07/12/2007 | WO2006136962A3 Airway administration of tissue factor pathway inhibitor in inflammatory conditons affecting the respiratory tract |
07/12/2007 | WO2006135783A3 Compositions and methods for modulating angiogenesis |
07/12/2007 | WO2006125201A3 Anti-biotin-pegylated-mcp-1 mutein antibodies, compositions, methods and uses |
07/12/2007 | WO2006123360A3 Microspheres containing octreotide acetate |
07/12/2007 | WO2006123256A3 Hivcon: an hiv immunogen and uses thereof |
07/12/2007 | WO2006105199A3 Compositions and methods for synthesis of peptide and related conjugate |
07/12/2007 | WO2006101387A3 Method for interfering with blood coagulation by modulating cross-beta structures fibril formation |
07/12/2007 | WO2006099330A3 Compositions comprising modulators of g-protein-coupled receptor for treatment of macular degeneration |
07/12/2007 | WO2006091795A3 METHODS AND COMPOSITIONS INVOLVING EXPRESSION OF α1C SUBUNIT OF L-TYPE CALCIUM CHANNELS IN SMOOTH MUSCLE CELLS |
07/12/2007 | WO2006091722A3 Alkyl-glycoside enhanced vaccination |
07/12/2007 | WO2006091610A3 Inhibitors of enveloped virus infectivity |
07/12/2007 | WO2006084131A3 Furin inhibitors and alpha-defensins for the treatment or prevention of papillomavirus infection |
07/12/2007 | WO2006025995A3 Compositions and methods using md-2 mutants and chimeric proteins |
07/12/2007 | WO2006017295A3 Tetrapeptide analogs |
07/12/2007 | WO2005097184A3 Antibodies against nogo receptor |
07/12/2007 | WO2005077094A3 Pancreatic polypeptide family motifs and polypeptides comprising the same |
07/12/2007 | WO2005058229A3 Antiviral proteins with improved properties and methods therefor |
07/12/2007 | WO2005037232A3 Methods and compositions for modulating adipocyte function |
07/12/2007 | WO2005019409A3 Combinatorial protein library screening by periplasmic expression |
07/12/2007 | WO2004104166A3 Administration of hyaluronic acid to enhance the function of transplanted stem cells |
07/12/2007 | US20070162994 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof |
07/12/2007 | US20070162987 Modulation of body weights; dietetics; eating disorders; for diagnostic and therapeutic implications in homeostasis of body weight and adipose tissue mass |
07/12/2007 | US20070162984 STARS-a muscle-specific actin-binding protein |
07/12/2007 | US20070161789 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
07/12/2007 | US20070161781 Therapeutic human albumin solutions with low prekallicrein activator (pka) activity and process for obtaining them |
07/12/2007 | US20070161711 Process for producing pellets for pharmaceutical compositions |
07/12/2007 | US20070161708 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate |
07/12/2007 | US20070161692 Conformationally restricted polyamine analogs as disease therapies |